hotspot -WSS

hotspot

author：entertainment 2025-10-01 15:30:42 - browse：22

Doctor Monica Bertagnolli, a white woman with short hair and bangs, sits at a hearing behind her name tag — coverage from STAT — National Institutes of Health Director Monica Bertagnolli testifies during her Senate HELP Committee confirmation hearing on Oct. 18 in Washington. Kevin Dietsch/Getty Images

WASHINGTON — The new National Institutes of Health director, Monica Bertagnolli, said it’s a “failure” that enrollment in government-funded clinical trials has lagged behind those funded by the pharmaceutical industry.

“If you just look at the number of patients who go on government-funded trials, it’s been completely flat over the last decade,” she said at a meeting of the advocacy group Friends of Cancer Research. “If you go and look at the number of people who go on pharma-sponsored trials, it’s just this commitment and this increase.”

A Johns Hopkins University study published in 2015 showed that the pharmaceutical industry funds six times more clinical trials than the government. Industry-sponsored trials increased 43% from 2006 to 2014, while newly registered NIH-funded trials decreased 24% over the same period.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： STAT Summit: How researchers deal with rejection

leisure time

WSS

CDC director unscathed in first congressional testimony

Takeda, Janssen join wearable maker to measure scratching

STAT Summit: The economic case for universal basic health care

STAT Summit: Meghan O’Rourke on making chronic illness visible

As biotech industry slumps, bioscience job market is upside down

Despite FDA concern, risk that CAR

knowledge

hotspot

knowledge

Moonlake's readout produced a cash windfall. Risks remain

How to pay for weight loss drugs and save Medicare

Medical records are filled with copy

Takeda, Janssen join wearable maker to measure scratching

Psychedelics group wrestles with new pharma identity

STAT Readout: Friday, Oct. 20 biotech updates

Duchenne breakthrough therapy leaves behind pioneering families

UnitedHealth’s Optum accused of antitrust violations in California

New air purifier tech could be key to improving indoor air quality

Diagnostic tests are hitting their mathematical limits

entertainment

Smaller biotechs seek to piggyback on weight loss drug boom

The EPA's new lead rule: How one expert crunched the numbers

BIO selects John Crowley as new CEO

STAT Summit: The economic case for universal basic health care

As biotech industry slumps, bioscience job market is upside down

Roivant's CEO is a star, but biotech's black hole persists

hotspot

focus

leisure time

hotspot